Article information
RESUMO
Entende-se por iatrogenia a doença provocada por actos praticados ou omitidos pelo médico, a vários níveis, destacandose, neste trabalho, o da terapêutica farmacológica. As informações existentes sobre os efeitos adversos dos fármacos ao nível do Aparelho Respiratório são escassas, dispersas e, muitas vezes, antigas, sendo as referências mais recentes sobretudo relacionadas com fármacos de investigação e utilização recente. Os fármacos podem provocar efeitos adversos à vários níveis: no interstício, nos vasos, nas vias aéreas baixas ou altas, no mediastino, na pleura, nos músculos ou nervos que controlam a mecânica ventilatória, etc. Descrevem-se neste trabalho os efeitos adversos de vários fármacos no contexto do Aparelho Respiratório.
REV PORT PNEUMOL 2002; VIII (6): 581-607
Palavras-chave:
iatrogenia
fármacos
pulmão
internet
ABSTRACT
Iatrogeny is disease caused by medical action or omission, mainly at the therapeutic level. Recently introduced drugs are commonly investigated extensively as regards adverse effects. Information on this subject is often scarce and disperse when medications in use for a long time are concerned. We review adverse effects of therapeutic agents in the Respiratory System
REV PORT PNEUMOL 2002; VIII (6): 581-607
Key-words:
iatrogeny
drugs
lung
internet
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
A. Soares.
Iatrogenia - Velhos e novos aspectos da face velada da Medicina.
Medicina Interna, 2 (1995), pp. 122-133
[2.]
ARAÚJO A, PRISCA S, BRAGANÇA F et al. Impact of the creation of the regional pharmacovigilance centres in the portuguese pharmacovigilance system. Apresentado no 4.º Congresso Nacional de SIDA. (dados não publicados.
[4.]
D. Israel-Biet, S. Labrune, G.J. Huchon.
Druginduced lung disease: 1990 review.
Eur Respir J, 4 (1991), pp. 465-478
[5.]
G.M. Akoun, S. Gauthier-Rahman, B.J. Milleron, J.Y. Perrot, C.M. Mayaud.
Amiodarone-induced hypersensitivity pneumonitis. Evidence of an immunological cell-mediated mechanism.
Chest, 85 (1984), pp. 133-135
[6.]
W.J. Picher, L. Schindler, M. Staubli, et al.
Antiamiodarone antibodies: detection and relationship to the development of side-efects.
Am J Med, 85 (1988), pp. 197-202
[7.]
G. Akoun, S. Gauthier-Rahman, C.M. Mayaud, et al.
Leukocyte migration inhibition in methotrexate induced pneumonitis. Evidence for an immunologic cellmediated mechanism.
Chest, 91 (1987), pp. 96-99
[8.]
D. Israel-Biet, A. Venet, D. Sandron, et al.
Pulmonary complications of intravesical BCG immunotherapy.
Am Rev Respir Dis, 135 (1987), pp. 763-765
[9.]
J.S. Lazo, W.W. Merril, E.T. Pham, et al.
Bleomycin hydrolase activity in pulmonary cells.
J Pharmacol Exp Ther, 231 (1984), pp. 583-588
[10.]
E.A. Sausville, R.W. Stein, J. Peisach, S.B. Horwitz.
Properties and products of the degradation of DNA by bleomycin and iron (II).
Biochemistry, 17 (1978), pp. 2746-2754
[11.]
J. Kelley, R.A. Newman, J.N. Evans.
Bleomycin-induced pulmonary fibrosis in the rat. Prevention with na inhibitor of collagen synthesis.
J Lab Clin Med, 96 (1980), pp. 954-964
[12.]
L. Einhorn, M. Krause, N. Hornback, B. Furnas.
Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell cancer.
Cancer, 37 (1976), pp. 2414-2416
[13.]
P.L. Goldiner, G.C. Carlon, E. Cvitkovic, O. Schweizer, W.S. Howland.
Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.
Br Med J, 1 (1978), pp. 1664-1667
[14.]
K.A. Bauer, A.T. Skarin, J.P. Balikian, et al.
Pulmonary complications associated with combination chemotherapy programs containig bleomycin.
Am J Med, 74 (1983), pp. 557-563
[15.]
D.J. Perry, R.B. Weiss, H.G. Taylor.
Enhanced bleomycin toxicity during acute renal failure.
Cancer Treat Resp, 66 (1982), pp. 592-593
[16.]
K.R. Cooper, W.K. Hong.
Prospective study of the pulmonary toxicity of continuously infused bleomycin.
Cancer Treat Resp, 65 (1981), pp. 419-425
[17.]
I.M. Krakoff, E. Cvitkovic, V. Currie, S. Yem, C. La Monte.
Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusion.
Cancer, 40 (1977), pp. 2027-2037
[18.]
R.B. Weiss, F.M. Muggia.
Cytotoxic drug-induced pulmonary disease: update 1980.
Am J Med, 68 (1980), pp. 259-266
[19.]
S.T. Crooke, L.H. Einhorn, R.L. Comis, J.C. D’Aoust, A.W. Prestayko.
The effects of prior exposure to bleomycin on the incidence of pulmonary toxicities.
Med Pediatr Oncol, 5 (1978), pp. 93-98
[20.]
B.A. Arrick, C.F. Nathan.
Glutathion metabolism as a determinant of therapeutic efficacy: a review.
Cancer Res, 44 (1984), pp. 4224-4232
[21.]
M.A. Sasame, M.R. Boyd.
Superoxyde and hydrogen peroxyde production and NADPH oxydation stimulated by nitrofurantoin in lung microsomes: possible implications for toxicity.
Life Sc, 24 (1979), pp. 1091-1096
[22.]
B.E. Ninmni, L.A. Bavetta.
Colagen defect induced by penicillamine.
Science, 150 (1965), pp. 205-207
[23.]
M. Adam, K. Kunh.
Investigations on the reactions of metals with collagen in vivo. Comparison of the reaction of gold thiosulfate with collagen in vivo and in vitro.
Eur J Biochem, 3 (1968), pp. 407-410
[24.]
J. Pastanen, A.M. Van Assendelft, S. Koskimies, et al.
Patients with rheumatoid arthritis and gold-induced pneumonitis express two high-risk major histo-compatibility complex patterns.
Chest, 92 (1987), pp. 277-281
[25.]
T.F. Morley, H.J. Komansky, R.A. Adelizzi, J.C. Gindice.
Pulmonary gold toxicity.
Eur J Respir Dis, 65 (1984), pp. 627-632
[27.]
G.M. Akoun, D.P. Herman, C.M. Mayaud.
Acebutolol-induced hypersensitivity pneumonitis.
Br Med J, 1 (1983), pp. 266-267
[28.]
M.B. Levy, J.N. Fink, P.A. Guzetta.
Nadolol and hypersensitivity pneumonitis.
Ann Intern Med, 105 (1986), pp. 806-807
[29.]
D. Vacher, O. Aumaître, P. Mignot, J. Lavarenne, C. Molina.
Alvéolite allergique médicamenteuse et syndrome de Parsonnage et Turner chez un malade taité par labetalol.
Presse Med, 16 (1987), pp. 539-540
[30.]
W.C. Stephan, R.D. Parks, B. Tempest.
Acute hypersensitivity pneumonitis associated with carbamazepine therapy.
Chest, 74 (1978), pp. 463-464
[31.]
T. Higgins, P.M. Niklasson.
Hypersensitivity pneumonitis induced by trimethoprim.
Br Med J, 1 (1990), pp. 1344
[32.]
D.C.F. Muir, J.A. Stanton.
Allergic pulmonary infiltration due to nitrofurantoin.
Br Med J, 1 (1963), pp. 1072
[33.]
G.S. Wang, K.Y. Yang, R.P. Perng.
Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere).
British Journal of Cancer, 85 (2001), pp. 1247-1250
[34.]
H.D. Sostman, R.A. Matthay, C.E. Putman, G.J. Walker Smith.
Methotrexate-induced pneumonitis.
Medicine (Baltimore), 55 (1976), pp. 371-388
[35.]
F. Lebecque, M. Mairesse.
Pneumopathie à la nitrofurantoine.
Poumon Coeur, 39 (1983), pp. 101-108
[36.]
L. Holmberg, G. Boman, L.E. Bottiger.
Adverse reactions to nitrofurantoin.
Am J Med, 69 (1980), pp. 733-738
[37.]
J.R. Graham, H.I. Suby, P.K. Lecompte, N.L. Sadowsky.
Fibrotic disorders associated with methysergide therapy for headaches.
N Engl J Med, 274 (1966), pp. 359-368
[38.]
M. Yokota, S. Matsukura, M. Kaji, et al.
Allergic reaction to DDAVP in diabetes insipidus: successful treatment with its graded doses.
Endocrinologia Japonica, 29 (1982), pp. 475-477
[39.]
D.W. Pusateri, R.R. Muder.
Fever, pulmonary infiltrates, and pleural effusion following acyclovir therapy for herpes zoster opthtalmicus.
Chest, 98 (1990), pp. 754-756
[40.]
T. Suhara, Y. Sudo, K. Yoshida, et al.
Lung as reservoir for antidepressants in pharmacokinetic drug interactions.
Lancet, 351 (1998), pp. 332-335
[41.]
E. De Kerviler, J. Trédaniel, G. Revlon, et al.
Fluo-xetin-induced pulmonary granulomatosis.
Eur Respir J, 9 (1996), pp. 615-617
[42.]
J.R. Panuska, T.R. King, P.E. Korenblat, H.J. Wedner.
Hypersensitivity reaction to desipramine.
J Allergy Clin Immunol, 80 (1987), pp. 18-23
[43.]
S. Salmeron, F. Brenot, B. Rain, et al.
Alvéolite allergique à la maprotiline: un cas documenté par lavage alvéolaire.
Rev Mal Respir, 5 (1988), pp. R139
[44.]
W. Habscheid, F. Feise, H.H. Dahm.
Miliary tuberculosis after intravesical instillation of bacillus CalmetteGuerin (BCG. for superficial bladder cancer.
Deutsche Medizinische Wochenschrif, 124 (1999), pp. 993-997
[45.]
J. Rabe, K.W. Neff, K.J. Lehmann, U. Mechtersheimer, M. Georgi.
Miliary tuberculosis after intravesical bacille Calmette-Guérin immunotherapy for carcinoma of the bladder.
Am J Roentgenol, 172 (1999), pp. 748-750
[46.]
K. Chin, C. Tabata, N. Satake, S. Nagai, F. Moriyasu, K. Kuno.
Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C.
Chest, 105 (1994), pp. 939-941
[47.]
K. Chin, C. Tabata, N. Satake, S. Nagai, F. Moriyasu, K. Kuno.
Pneumonitis associated With natural and recombinant interferon alfa therapy for chronic hepatitis C.
Chest, 105 (1994), pp. 939-941
[48.]
T. Kamisako, Y. Adachi, J. Chihara, T. Yamamoto.
Interstitial pneumonitis and interferon-alfa.
Br Med J, 306 (1993), pp. 896
[49.]
C.J. Eastmond.
Diffuse alveolitis as complication of penicillamine treatment for rheumatoid arthritis.
Br Med J, 1 (1976), pp. 1506
[50.]
P. Camus, O. Reybet-Degat, E. Justrabo, L. Jeannin.
D-penicillamine-induced severe pneumonitis.
Chest, 81 (1982), pp. 376-378
[51.]
W.E. Mahon, D.J. Scott, G. Ansell, G.L. Manson, R. Fraser.
Hypersensitivity to pituitary snuff with miliary shadowing in the lungs.
Thorax, 22 (1967), pp. 13-20
[52.]
J.R. Collins.
Adverse reactions to salicylazosulfapyridine (Azulfidine. in the treatment of ulcerative colitis.
South Med J, 61 (1968), pp. 354-358
[53.]
A. Martin, E. Legrand, B. Desrues, et al.
Sulfasalazine et poumons. A propos d’une observation de pneumopathie d’hypersensibilité au cours d’une polyarthrite rhumatoïde.
Sem Hop Paris, 64 (1988), pp. 2174-2177
[54.]
A. Sigvaldason, S. Sörenson.
Interstitial pneumonia due to sulfasalazine.
Eur J Respir Dis, 64 (1983), pp. 229-233
[55.]
R. Bassen, H. Lena, E. Briens, et al.
Atenolol-induced interstitial pneumonia.
Ann Med Interne, 148 (1997), pp. 505-507
[57.]
L.D. Suarez, J.J. Poderoso, B. Elsner, M. Bunster, H. Esteva, M. Bellotti.
Subacute pneumopathy during amiodarone therapy.
Chest, 83 (1983), pp. 566-568
[58.]
P.T. Wilsmhurst, M.M. Webb-Peploe.
Side effects of amrinone therapy.
Br Heart J, 49 (1983), pp. 447-451
[59.]
R.L. Kaplan.
Pulmonary effects of carmustine (bischlo-roethylnitrosourea.
BCNU. Ann Intern Med, 91 (1979), pp. 131
[60.]
P.L. Schatz, D. Mesologites, J. Hyun, G.J. Walker Smith, B. Lahiri.
Captopril-induced hypersensitivity lung disease. An immune-complex-mediated phenomenon.
Chest, 95 (1989), pp. 685-687
[61.]
P.M. Roelofs, P.J. Klinkhamer, H.C. Gooszen.
Hypersensitivity pneumonitis probably caused by cyclosporine. A case report.
Respir Med, 92 (1998), pp. 1368-1370
[62.]
F.A. Rubio Jr..
Possible pulmonary effects of alkylating agents.
N Engl J Med, 287 (1972), pp. 1150-1151
[63.]
R.B. Dawson Jr..
Pulmonary reactions to nitrofurantoin.
N Engl J Med, 274 (1966), pp. 522
[64.]
E. Gascard, C. Boutin, P. Cargnino, J.-P. Girbal.
Infiltrat labile provoqué par un sulfamide retard.
Marseille Med, 106 (1969), pp. 891-893
[65.]
J.C. Guérin, J.P. Chevalier, J. Kofman, et al.
Pneumopathies interstitielles médicamenteuses après traitement par le cotrimoxazole. Deux observations.
Presse Med, 9 (1980), pp. 2347
[66.]
L.W. Burgher, I. Kass, J.R. Schenken.
Pulmonary allergic granulomatosis: a possible drug reaction in a patient receiving cromolyn sodium.
Chest, 66 (1974), pp. 84-86
[67.]
A.S. Bayer, S.R. Targan, H.E. Pitchon, L.B. Guze.
Dilantin toxicity: miliary pulmonary infiltrates and hypoxemia.
Ann Intern Med, 85 (1976), pp. 475-476
[68.]
M. Katoh, K. Shikoshi, M. Takada, et al.
Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor.
Ann Hematol, 67 (1993), pp. 201-202
[69.]
C. Beaudry, L. Laplante.
Severe allergic pneumonitis from hydrochlorothiazide.
Ann Intern Med, 78 (1973), pp. 251-253
[70.]
L. Klapholz, E. Leitersdorf, L. Weinrauch.
Leucocytoclastic vasculitis and pneumonitis induced by metformin.
Br Med J, 293 (1986), pp. 483
[71.]
R. Ishibashi, Y. Takagi, S. Ozaki.
A case with glibenclamide induced pneumonitis.
Nippon Kyobu Rinsho, 58 (1999), pp. 762
[72.]
R.L. Kaplan, D.H. Waite.
Progressive interstitial lung disease from prolonged methotrexate therapy.
Arch Dermatol, 114 (1978), pp. 1800-1802
[73.]
E.S. Orwoll, P. Kiessling, R. Patterson.
Interstitial pneumonia from mitomycin.
Ann Intern Med, 89 (1978), pp. 352-355
[74.]
A. Poukkula, P. Päkkö.
Quinidine-induced reversible pneumonitis.
Chest, 106 (1994), pp. 304-306
[75.]
J.V. Collis, A.L. Thomas.
Pulmonary reaction to furoxone.
Postgrad Med J, 49 (1973), pp. 518-520
[76.]
H. Noh, Y.K. Lee, S.W. Kang, K.H. Choi, D.S. Han, H.Y. Lee.
Acute eosinophilic pneumonia associated with amitriptyline in a hemodialysis patient.
Yonsei Medical Journal, 42 (2001), pp. 357-359
[77.]
R.J. Joynt, J. Clancy.
Extreme eosinophilia during imipramine therapy.
Am J Psychiatry, 118 (1961), pp. 170-171
[78.]
L. Grcevska, M. Polenakovic, G. Breskowska.
Focal segmental glomerular-sclerosis-like lesions associated with eosinophilic pneumonia and trimethoprim and penicillin treatment.
Nephron, 64 (1993), pp. 325-326
[79.]
A.G. Lim, K.R. Hine.
Fever, vasculitic rash, arthritis, pericarditis, and pericardial effusion after mesalazine.
Br Med J, 1 (1994), pp. 113
[80.]
J. Scherpenisse, P.M. Van Der Valk, J.N.M. Van Den Bosch, P.A.M. Van Hees, J.H.S.M. Nadorp.
Olsalazine as analternative therapy in a patient with sulfasalazine-induced eosinophilic pneumonia.
J Clin Gastroenterol, 10 (1988), pp. 218-220
[81.]
J.M. Sabio, J. Jimenez-Alonso, F. Gonzalezcrespo.
More about Churg-Strauss syndrome and montelukast treatment.
Chest, 120 (2001), pp. 2114
[82.]
C. Mendonça, A. Pereira, S. Longo, N. Lousada, A. Loureiro, J.F. Correia.
Amiodarone and the lung.
Rev Port Cardiol, 15 (1996), pp. 745-751
[83.]
L.R. Klotz, S.D. Klotz, R.K. Moeller.
The use of beclomethasone dipropionate inhaler complicated by the development of an eosinophilic pneumonia reaction.
Ann Allergy, 39 (1977), pp. 133-136
[84.]
K. Watanabe, K. Nishimura, M. Shiode, et al.
Captopril, an angiotensin-converting enzyme inhibitor induced pulmonary infiltration with eosinophilia.
Intern Med, 35 (1996), pp. 142-145
[85.]
T. Lee, G.M. Cochrane.
Pulmonary eosinophilia and asthma associated with carbamazepine.
Br Med J, 282 (1981), pp. 440
[86.]
J. Smith, V.F. Weinstein.
Cephalexin-associated pulmonary infiltration with circulating eosinophilia.
Br Med J, 294 (1987), pp. 776
[87.]
S. Kohno, K. Yamaguchi, A. Yasuoka, et al.
Clinical evaluation of 12 cases of antimicrobial drug-induced pneumonitis.
Jpn J Med, 29 (1990), pp. 248-254
[88.]
B.G. Clark, R.E. Vestal.
Adverse drug reactions in the elderly: case studies.
Geriatrics, 39 (1984), pp. 53-54
[90.]
H. Khalil, E. Molinari, J.K. Stoller.
Diclofenac (Voltaren.-induced eosinophilic pneumonitis.
Arch Intern Med, 153 (1993), pp. 1649-1652
[91.]
M. Mahatma, E.F. Haponik, S. Nelson, A. Lopez, W.R. Summer.
Phenytoin-induced acute respiratory failure with pulmonary eosinophilia.
Am J Med, 87 (1989), pp. 93-94
[92.]
R.T. Cuthbert.
Löffler’s syndrome occurring during streptomycin and PAS therapy.
Br Med J, ii (1954), pp. 398-399
[93.]
P.C. Wong, W.W. Yew, C.F. Wong, H.Y. Choi.
Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement.
Eur Respir J, 8 (1995), pp. 866-868
[94.]
S.J. Brandt, W.P. Peters, S. Atwater, et al.
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
N Engl J Med, 318 (1988), pp. 869-876
[95.]
Y. Oishi, Y. Sando, S. Tajima, et al.
Indomethacin induced bulky lymphadenopathy and eosinophilic pneumonia.
Respirology, 6 (2001), pp. 57-60
[96.]
G. Oliviero, P. Constans, I. Caby, P. De Rohanchabot, J.C. Lacherade.
Pneumopathie induite par l’isotretinoïne.
Rev Mal Respir, 12 (1995), pp. 631-633
[97.]
F. Berrissoul, S. Ang-Chin, D. Mongin-Charpin, J. Payot, P. Guibout.
Pneumopathie à éosinophiles due au paracetamol.
Premier cas de la littérature. Rev Mal Respir, 3 (1986), pp. 282
[98.]
D. Davies, J.K. Lloyd Jones.
Pulmonary eosinophilia caused by penicillamine.
Thorax, 35 (1980), pp. 957-958
[99.]
A. Ducoloné, A. Vandevenne, P. Ringwald, G. Burghard.
Poumon éosinophile d’origine médicamenteuse.
Sem Hop Paris, 62 (1986), pp. 1107-1110
[100.]
A. Dietz, C. Hubner, K. Andrassy.
Makrolid-Antibiotika induzierte Vaskulitis (Churg-Strauss-Syndrom.
Laryngo-Rhino-Otol, 77 (1998), pp. 111-114
[101.]
R. Souquet, J. Brun, M. Martoia, J. Gilly.
La miliaire pulmonaire éosinophilique de nature allergique au cours de la chrysothérapie.
Poumon Coeur, 30 (1974), pp. 85-90
[102.]
R. Souquet, J. Brun, M. Martoia, J. Gilly.
Miliaire pulmonaire éosinophilique au cours d’une chrysothérapie.
Rev Fr Allergol, 14 (1974), pp. 85-89
[103.]
P.T. Daniel, J. Holzschuh, P.A. Berg.
Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).
Thorax, 44 (1989), pp. 307-309
[104.]
K.K. Wang, B.A. Bowyer, C.R. Fleming, K.W. Schroeder.
Pulmonary infiltrates and eosinophilia associated with sulfasalazine.
Mayo Clin Proc, 59 (1984), pp. 343-346
[105.]
D. Ho, D.P. Tashkin, M.E. Bein, O. Sharma.
Pulmonary infiltrates with eosinophilia associated with tetracycline.
Chest, 76 (1979), pp. 33-36
[106.]
C.R. Swinburn, G.J. Jackson, I. Cobden, T. Ashcroft, G.N. Moritt, P.A. Corris.
Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis.
Thorax, 43 (1988), pp. 735-736
[107.]
F. Philip-Joet, J. Orehek, D. Vervloet, A. Ar- Naud.
Bronchiolites oblitérantes après prise de d-pénicillamine (Trolovol*. dans le traitement de la polyarthrite rhumatoïde.
J Med Marseille, 2 (1983), pp. 245-246
[108.]
A.J. Cohen, J.R. Kingte, G.P. Downey.
Rapidly progressive bronchiolitis obliterans with organizing pneumonia.
Am J Respir Crit Care Med, 149 (1994), pp. 1670-1675
[109.]
S.J. Pegg, B.A. Lang, E.L. Mikhail, D.M. Hughes.
Fatal bronchiolitis obliterans in a patient with juvenile rheumatoid arthritis receiving chrysotherapy.
J Rheumatol, 21 (1994), pp. 549-551
[110.]
K.J. Schwartzman, D.M. Bowie, C. Yeadon, R. Fraser, E.D. Sutton, R.D. Levy.
Constrictive bronchiolitis obliterans following gold therapy for psoriatic arthritis.
Eur Respir J, 8 (1995), pp. 2191-2193
[111.]
S. Oren, S. Turkot, B. Golzman, D. London, D. Bendor, Z. Weiler.
Amiodarone-induced bronchiolitis obliterans organizing pneumonia (BOOP.
Respir Med, 90 (1996), pp. 167-169
[112.]
S. Krimerman, I. Potasman, A. Barak.
Pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusion.
Crit Care Med, 17 (1989), pp. 1081
[113.]
P. Angle, P. Thomas, B. Chiu, J. Freedman.
Bronchiolitis obliterans with organizing pneumonia and cold agglutinin disease associated with phenytoin hypersensitivity syndrome.
Chest, 112 (1997), pp. 1697-1699
[114.]
K. Ogata, T. Koga, K. Yagawa.
Interferon-related bronchiolitis obliterans organizing pneumonia.
Chest, 106 (1994), pp. 612-613
[115.]
D. Ferriby, T. Stojkovic.
Bronchiolitis obliterans with organizing pneumonia during interferon ß-1a treatment.
Lancet, 357 (2001), pp. 751
[116.]
J.L. Alonso-Martinez, J.I. Elejalde-Guerra, D. Larrinaga-Linero.
Bronchiolitis obliterans organizing pneumonia caused by ticlopidine.
Ann Intern Med, 129 (1998), pp. 71-72
[117.]
J.C. Kidney, D.J. O’Halloran, M.X. Fitzgerald.
Captopril and lymphocytic alveolitis.
Br Med J, 299 (1989), pp. 981
[118.]
D.W. Chamberlain, R.H. Hyland, D.J. Ross.
Diphenylhydantoin-induced lymphocytic interstitial pneumonia.
Chest, 90 (1986), pp. 458-460
[119.]
D.A. White, D.E. Stover.
Severe bleomycin-induced pneumonitis: clinical features and response to corticosteroids.
Chest, 86 (1984), pp. 723-728
[120.]
J.A.D. Cooper, D.A. White, R.A. Matthay.
Drug-induced pulmonary disease.
Am Rev Respir Dis, 133 (1986), pp. 321-340
[122.]
J. Morera, R. Vidal, F. Morell, J. Ruiz, L. Bernado, J.R. Laporte.
Amiodarone and pulmonary fibrosis.
Eur J Clin Pharmacol, 24 (1983), pp. 591-593
[123.]
A. Kheir, F. Chabot, N. Delorme, J.M. Polu.
Pneumopathie fibrosante induite par le labétalol.
Rev Pneumol Clin, 52 (1996), pp. 33-35
[124.]
T.M. Erwteman, M.C.P. Braat, W.G. Van Aken.
Interstitial pulmonary fibrosis: a new side effect of practolol.
Br Med J, ii (1977), pp. 297-298
[125.]
A.W. Musk, J.A. Pollard.
Pindolol and pulmonary fibrosis.
Br Med J, 11 (1979), pp. 581-582
[126.]
Abdel F.W. Karim, R.E. Ayash, C. Allam, P.A. Salem.
Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide.
Oncology, 40 (1983), pp. 174-176
[127.]
A. Zomas, J.C.W. Marsh, N.K. Harrison, et al.
Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anemia.
Ann Hematol, 71 (1995), pp. 49-51
[128.]
G. Goucher, V. Rowland, J. Hawkins.
Melphalan-induced pulmonary interstitial fibrosis.
Chest, 77 (1980), pp. 805-806
[129.]
B.W. Codling, T.M.H. Chakera.
Pulmonary fibrosis following therapy with melphalan for multiple myeloma.
J Clin Pathol, 25 (1972), pp. 668-673
[130.]
G. Routier, P. Langeron, R. Empereur-Buisson, Croccel L. Boutroy.
Aorto-iliac compression revealing retroperitoneal fibrosis during methysergide treatment.
Ann Med Interne (Paris), 120 (1969), pp. 669-676
[131.]
J.R. Graham, H.I. Suby, P.R. Lecompte, Sad N.L. Owsky.
Fibrotic disorders associated with methy sergide therapy for headache.
N Engl J Med, 274 (1966), pp. 359-368
[132.]
R.P. Bays.
Pleuropulmonary fibrosis following therapy with methysergide maleate: two case reports.
J La State Med Soc, 120 (1968), pp. 426-427
[133.]
R.G. Graham.
Cardiac and pulmonary fibrosis during methysergide therapy for headache.
Am J Med Sci, 254 (1967), pp. 1-12
[134.]
S.M. Bentzen, J.Z. Skoczylas, M. Overgaard, J. Overgaard.
Radiotherapy-related lung fibrosis enhanced by tamoxifen.
J. Natl. Cancer Inst, 88 (1996), pp. 918-922
[135.]
J. Vergeret, M. Barat, A. Taytard, et al.
Fibrose pleuro-pulmonaire et bromocriptine.
Sem Hop Paris, 60 (1984), pp. 741-744
[136.]
J.G. Fort, H. Scovern, J.L. Abruzzo.
Intravenous cyclophosphamide and methylprednisolone for the treatment of bronchiolitis obliterans and interstitial fibrosis associated with chrysotherapy.
J Rheumatol, 15 (1988), pp. 850-854
[137.]
T. Williams, L. Eidus, P. Thomas.
Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy.
Chest, 81 (1982), pp. 766-768
[138.]
J.M. Bauer, R.H. Freyberg.
Vitamin D intoxication with metastatic calcification.
JAMA, 130 (1946), pp. 1208-1215
[139.]
B. Patri, et al.
Insuffisance respiratoire aigue au cours d’une pneumopathie huileuse diffuse.
Ann Med Intern, 129 (1978), pp. 543-546
[140.]
J. Casademont, A. Xaubet, M.O.J. Lopez-Guiller, et al.
Radiographic bilateral cavitary lesions in lipoid pneumonia.
Eur Respir J, 1 (1988), pp. 93-94
[141.]
G. Dougay, et al.
Paraffinose alvéolaire: étude cytologique lo-alveolaire. et biochimique du liquide de lavage bronchio.
Rev Fr Mal Respir, 2 (1985), pp. 231-237
[142.]
R.G. Crystal, J.E. Gadek, V.J. Ferrans, et al.
Interstitial lung disease: current concepts of pathogenesis, staging and therapy.
Am J Med, 70 (1981), pp. 542-568
[143.]
H.H. Rotmensch, M. Liron, M. Tupilaki, D.O.S. Lania.
Possible association of pneumonitis with amiodarone therapy.
Am Heart J, 100 (1980), pp. 412-413
[144.]
T. Pollak, M. Sami.
Acute necrotizing pneumonitis and hyperglycemia after amiodarone therapy.
Am J Med, 76 (1984), pp. 935-939
[145.]
R. Arnon, I. Raz, T. Chajek-Shaul, et al.
Amiodarone pulmonary toxicity presenting as a solitary lung mass.
Chest, 93 (1988), pp. 425-427
[146.]
R. Gonzales-Rothi, S. Hannan, I. Hood, D. Franzini.
Amiodarone pulmonary toxicity presenting as bilateral exudative pleural effusions.
Chest, 92 (1987), pp. 179-182
[147.]
J.R. Piccionew, L.P. Faber, M.S. Rosenberg.
Amiodarone-induced pulmonary mass.
Ann Thorac Surg, 47 (1989), pp. 918-919
[148.]
C.P. Criée, E. Wilhelms, M. Kneba, H. Kreuser.
Multiple pulmonary round opacities during treatment with amiodarone.
Dtsch Med Wochenschr, 109 (1984), pp. 499-500
[149.]
D. Israel-Biet, A. Venet, I. Caubarrère, et al.
Bronchoalveolar ization lavage in amiodarone pneumonitis: character of the cellular abnormalities and their relevance to the pathogenesis of the disease.
Chest, 91 (1987), pp. 214-221
[150.]
Y.Y. Zhu, E. Botvinick, M. Dae, et al.
Gallium lung scintigraphy in amiodarone pulmonary toxicity.
Chest, 93 (1988), pp. 1126-1131
[151.]
C. Muren, O. Strandberg.
Cavitary pulmonary nodules in atypical collagen disease and lupoid drug reaction.
Acta Radiol, 30 (1989), pp. 281-284
[152.]
H.A.M. Sinnige, C.A. Boender, E.W. Kuypers, H.M. Ruitenberg.
Carbamazepine-induced pseudolymphoma and immune dysregulation.
J Intern Med, 227 (1990), pp. 355-358
[153.]
C. Muren, O. Strandberg.
Cavitary pulmonary nodules in atypical collagen disease and lupoid drug reaction.
Acta Radiol, 30 (1989), pp. 281-284
[154.]
J.E. Heffner, S.A. Sahn.
Salicylate-induced pulmonary Med, 95 (1981), pp. 405-409
[155.]
N. Ersoz, S.C. Finestone.
Adrenaline-induced pulmonary oedema and its treatment. A report of two cases.
Br J Anaesth, 43 (1971), pp. 709-712
[156.]
H.P. Liu, K.C. Wu, P.P. Lu, et al.
Delayed-onset epinephrine-induced pulmonary edema.
Anesthesiology, 91 (1999), pp. 1169-1170
[157.]
K.G. Chetty, M.M. Ramirez, C.K. Mahutte.
Drug-induced pulmonary edema in a patient infected with human immunodeficiency syndrome.
Chest, 104 (1993), pp. 967-969
[158.]
P.G. Stubblefield.
Pulmonary edema occurring after therapy with dexamethasone and terbutaline for pre mature labor.
Am J Obstet Gynecol, 132 (1978), pp. 341-342
[159.]
A.D. Steinberg.
Pulmonary edema following ingestion of hydrochlorothiazide.
JAMA, 204 (1968), pp. 167-168
[160.]
T.C. Farrell, R.F. Schillaci.
Hydrochlorothiazideinduced pulmonary edema mimicking metastatic carcino ma of the breast.
Cardiopulmonary Med, 15 (1976), pp. 16-17
[161.]
I.R. Preston, J.R. Klinger, J. Houtchens, D. Nelson, S. Mehta, N.S. Hill.
Pulmonary edema caused by inhaled nitric oxide therapy in tow patients with pulmonary hypertension associated with the CREST syndrome.
Chest, 121 (2002), pp. 656-659
[162.]
C.J.D. Reid, M.J. Marsh, M. Murdochi, G. Clark.
Nephrotic syndrome in childhood complicated by life threatening pulmonary oedema.
Br Med J, 1 (1996), pp. 36-38
[163.]
A. Tracqui, C. Tournoud, F. Flesch, et al.
Buprenorphine poisoning in drug abusers on substitution therapy: 29 non-fatal and 20 fatal cases.
Presse Med, 27 (1998), pp. 557-561
[164.]
G.E. Kitson, T.D. Wauchob.
Pulmonary oedema following carbamazepine overdose.
Anaesthesia, 43 (1988), pp. 967-969
[165.]
L.J. Bogartz, W.C. Miller.
Pulmonary edema associated with propoxyphen intoxication.
JAMA, 215 (1971), pp. 259
[166.]
M. Nevins, S. Berque, N. Corwin, L. Lyon.
Phenyl butazone and pulmonary oedema.
Lancet, 11 (1969), pp. 1358
[167.]
R.T. Schooley, P.F. Wagley, P.S. Lietman.
Edema associated with ibuprofen therapy.
JAMA, 237 (1977), pp. 1716-1717
[168.]
U.I. Frand, C.S. Shim, M.H. Williams.
Methadoneinduced pulmonary edema.
Ann Intern Med, 76 (1972), pp. 975-979
[169.]
J.W. Flacke, W.E. Flacke, G.D. Williams.
Acute pulmonary edema following naloxone reversal of highdose morphine anesthesia.
Anesthesiology, 47 (1977), pp. 376-378
[170.]
R.H. Taff.
Pulmonary edema following naloxone administration in a patient without heart disease.
Anesthesiology, 59 (1983), pp. 576-577
[171.]
E.R. Gonzalez, T. Cole, M.M. Grimes, R.A. Fink, A.A.I. Fowler.
Recurrent ARDS in an 39-year-old woman with migraine headaches.
Chest, 114 (1998), pp. 919-922
[172.]
P.J. Asimacopoulos, I. Athanasiadis, J.J. McCarthy, R.J. Shade, R.B. Teague.
Can heparin cause adult respiratory distress syndrome by a similar mechanism as heparin-associated thrombocytopenia?.
Chest, 105 (1994), pp. 1266-1268
[173.]
J.P. Dieleman, B.I. Tveld, J.C.C. Borleffs, G. Schreij.
Acute respiratory failure associated with the human immunodeficiency virus (HIV. protease inhibitor indinavir in an HIV-infected patient.
Clin Infect Dis, 26 (1998), pp. 1012-1013
[174.]
M. Saussine, P. Colson, M. Alauzen, H. Mary.
Postoperative acute respiratory distress syndrome. A complication of amiodarone associated with 100 percent oxygen ventilation.
Chest, 102 (1992), pp. 980-981
[175.]
F.D. Lindström, O. Flodmark, B. Gustafsson.
Respiratory distress syndrome and thrombotic, nonbacterial endocarditis after amitriptyline overdose.
Acta Med Scand, 202 (1977), pp. 203-212
[176.]
R.M. Varnell, J.D. Godwin, M.L. Richardson, J.M. Vincent.
Adult respiratory distress syndrome from overdose of tricyclic antidepressants.
Radiology, 170 (1989), pp. 667-670
[177.]
V.H. Humbert, N.J. Munn, R.F. Hawkins.
Noncardiogenic pulmonary edema complicating massive diltiazem overdose.
Chest, 99 (1991), pp. 258-260
[178.]
L.A. Abramov, I.C. Yust, E.M. Fierstater, N.E. Vardinon.
Acute respiratory distress caused by erythromycin hypersensitivity.
Arch Intern Med, 138 (1978), pp. 1156-1158
[179.]
R.A. Tio, R.H.A.M. Voorbij, R. Enthoven.
Adult respiratory distress syndrome after streptokinase.
Am J Cardiol, 70 (1992), pp. 1632-1633
[180.]
G. Verhoef, M. Boogaerts.
Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome.
Am J Hematol, 36 (1991), pp. 285-287
[181.]
M.R. Dorn, B.K. Walker.
Noncardiogenic pulmonary edema associated with hydrochlorothiazide therapy.
Chest, 79 (1981), pp. 482-483
[182.]
M.C. Dooren, W.H. Ouwehand, A.J. Verhoeven, A.E.G.K. Von Dem Borne, R.W.A.M. Kuijpers.
Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies.
Lancet, 352 (1998), pp. 1601
[183.]
J. Russel, S. Follansbee, M. Matthay.
Adult respiratory distress syndrome complicating diabetic ketoacidosis.
West J Med, 135 (1981), pp. 148-150
[184.]
R. Sheldon, D. Slaughter.
A syndrome of microangiopathic hemolytic anemia, renal impairment and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
Cancer, 58 (1986), pp. 1428-1436
[185.]
M.J. Murray, R. Kronenberg.
Pulmonary reactions simulating cardiac pulmonary edema caused by nitrofurantoin.
N Engl J Med, 273 (1965), pp. 1185-1187
[186.]
C. Kindler, A. Bircher, P. Stulz.
Protamine-induced fulminating non-cardiogenic pulmonary edema following cardiopulmonary bypass.
Eur J Cardiothor Surg, 10 (1996), pp. 463-466
[187.]
A.D. Carilli, M.V. Ramamurthy, Y.-S. Chang, D. Shin, V. Sehti.
Noncardiogenic pulmonary edema following blood transfusion.
Chest, 74 (1978), pp. 310-312
[188.]
E. Boven, H.M. Pinedo, C. Mitomycin.
Interstitial pneumonitis and haemolytic-uraemic syndrome. A report of two cases and review of the literature.
Neth J Med, 26 (1983), pp. 153-156
[189.]
N.W. Lyman, R. Michaelson, R.L. Viscuso, R. Winn, S. Mulgaonkar, M.G. Jacobs.
Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasme exchange.
Arch Intern Med, 143 (1983), pp. 1617-1618
[191.]
I. Goldstein, M. Topilsky, D. Segev, A. Isakov, I. Heller.
Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis.
Chest, 111 (1997), pp. 1446-1447
[192.]
V.M. Yermakov, I.F. Hitti, A.L. Sutton.
Necrotizing vasculitis associated with diphenylhydantoin: two fatal cases.
Hum Pathol, 14 (1983), pp. 182-184
[193.]
L. Disler, A. Rosendorff.
Pulmonary hemorrhage following intravenous streptokinase for acute myocardial infarction.
Int J Cardiol, 29 (1990), pp. 387-390
[194.]
D. Lipsker, S. Walther, R. Schulz, S. Navé, B. Cribier.
Life-threatening vasculitis related to quinidine occurring in a healthy volunteer during a clinical trial.
Eur J Clin Pharmacol, 54 (1998), pp. 815
[195.]
E. Van Sonnenberg, G. Wittich.
Hemoptysis during lung biopsy after aspirin.
Am J Roentgenol, 171 (1998), pp. 261
[196.]
V.T. Barnett, F. Bergmann, H. Humphrey, J. Chediak.
Diffuse alveolar hemorrhage secondary to superwarfarin ingestion.
Chest, 102 (1992), pp. 1301-1302
[197.]
J.J. Egan, N. Martin, P.S. Hasleton, et al.
Pulmonary interstitial fibrosis and haemosiderin-laden macrophages: late following heart transplantation.
Respiration, 90 (1996), pp. 547-551
[198.]
P.K. Kilraru, M.J. Schweiger, H.A. Hozman, T.R. Weil.
Diffuse alveolar hemorrhage after clopidogrel use.
Journal of Invasive Cardiology, 13 (2001), pp. 535-537
[199.]
S. Louie, C.N. Gamble, C.E. Cross.
Penicillamine-associated pulmonary hemmorrhage.
J Rheumatol, 13 (1986), pp. 963-966
[200.]
P. Sternlieb, B. Bennett, I.H. Scheinberg.
Dpenicillamine induced Goodpasture’s syndrome in Wilson’s disease.
Ann Intern Med, 82 (1975), pp. 673-676
[201.]
I. Van Zyla, A.A. Jennings, E.D. Bateman, L.H. Opie.
Comparison of respiratory effects of two cardioselective beta blockers, celiprolol and atenolol in astmatics with mild to moderate hypertension.
Chest, 95 (1989), pp. 209-213
[202.]
I.P. Williams, F.J.C. Millard.
Severe asthma after inadvertent ingestion of oxprenolol.
Thorax, 35 (1980), pp. 160
[203.]
G. Akoun, B. Milleron, C. Mayaud, D. Tholoniat.
Provocation test coupled with bronchoalveolar lavage in diagnosis of propranolol-induced hypersensitivity pneumonitis.
Am Rev Respir Dis, 139 (1989), pp. 247-249
[204.]
P.W. Ind, C.M.S. Dixon, R.W. Fuller, P.J. Barnes.
Anticholinergic blockage of beta-bloquer-induced bronchoconstrition.
Am Rev Respir Dis, 139 (1989), pp. 1390-1394
[205.]
F.C. Hugues, D. Julien, Y. Munera, J. Marche.
Étude de la tolérance respiratoire des adrénolytiques bétabloquants chez l’asthmatique.
Nouv Presse Med, 7 (1978), pp. 2711-2714
[206.]
R.C. Kory, S.R. Hirsch, J. Giraldo.
Nebulization of N-acetylcysteine combined with a bronchodilator in patients with chronic bronchitis: a controlled study.
Chest, 54 (1968), pp. 504-509
[207.]
S.W.C. Ho, L.J. Beilin.
Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: report of two cases.
Br Med J, 287 (1983), pp. 876
[208.]
J. Yarbrough, L.E. Mansfield, S. Ting.
Metered dose inhaler-induced bronchospasm in asthmatic patients.
Ann Alergy, 55 (1985), pp. 25-27
[209.]
F. Widal, P. Abrami, J. Lermoyez.
Anaphylaxie et idiosyncrasie.
Nouv Presse Med, 30 (1922), pp. 189-191
[210.]
T.J. Fischer, T.D. Guilfoile, H.H. Kesarwala, et al.
Adverse pulmonary responses to aspirin and acetaminophen in chronic chilhood asthma.
Pediatrics, 71 (1983), pp. 313-318
[211.]
M. Samter, R.F. Beers.
Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.
Ann Intern Med, 68 (1968), pp. 975-983
[212.]
A. Szczeklik, R.J. Gryglewski, Czerniaw G. Ska-Mysik, R. Pieton.
Asthmatic attacks induced in aspirin-sensitive patients by diclofenac and naproxen.
Br Med J, 11 (1977), pp. 231-232
[213.]
J. Polachek, P. Shvartzman.
Acute bronchial asthma associated with the administration of ophthalmic indomethacin.
Isr J Med Sci, 32 (1996), pp. 1107-1109
[214.]
A. Szczeklik, R.J. Gryglewski, G. Czerniawska-Mysik, A. Zmuda.
Aspirin-induced asthma: hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different enzymatic preparations.
J Allergy Clin Immunol, 58 (1976), pp. 10-18
[215.]
E.J. Bini, E.H. Weinshel.
Severe exacerbation of asthma: A new side effect of interferon-alpha in patients with asthma and chronic hepatitis C.
Mayo Clin Proc, 74 (1999), pp. 367-370
[216.]
L.M.R. Cass, et al.
Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
Repiratory Medicine, 94 (2000), pp. 166-173
[217.]
Zanamivir e potencial risco de broncospasmo.
Bol Farmacovigil, 4 (2000), pp. 1
[218.]
D. Hund, P. Kertes, S. Venables, J. Callaghan, L.C. Harrison.
Exacerbation of bronchial asthma following treatment with amiodarone.
Chest, 86 (1984), pp. 492-494
[219.]
P. Pillans.
Bronchospasm associated with cisapride.
Br Med J, 311 (1995), pp. 1472
[220.]
E. Visetti, P. Costa.
Rhabdomyolysis following lifethreatening acute asthma attack.
Anaesthesia, 48 (1993), pp. 887-888
[221.]
P.E. Nathan, A.V. Torres, A.J. Smith, A.J. Gagliardi, K.B. Rapeport.
Spontaneous pulmonary hemorrhage following coronary thrombolysis.
Chest, 101 (1992), pp. 1150-1152
[222.]
R.A. Sabroe, R.C.D. Staughton, C.B. Bunker.
Bronchospasm induced by isotretinoin.
Br Med J, 312 (1996), pp. 886
[223.]
A.D. Farmery.
Severe unilateral bronchospasm mimicking inadvertent endobronchial intubation: a complication of the use of a topical lidocaine Laryngojet injector.
British Journal of Anaesthesia, 85 (2000), pp. 917-919
[224.]
P.V. Dicpinigaitis, S.A. Thomas, M.B. Sherman, Y.E. Gayle, D.L. Rosenstreich.
Losartan-induced bronchospasm.
J Allergy Clin Immunol, 98 (1996), pp. 1128-1130
[225.]
S. Fernandez, M. Reano, R. Vives, et al.
6-Meth-ylprednisolone-induced bronchospasm.
Allergy, 52 (1997), pp. 780-782
[226.]
M. Chung, K.G. Chetty, D. Jerome.
Metoclo pramide and asthma.
Ann Intern Med, 103 (1985), pp. 809
[227.]
A.S.M. McCormick, V.L. Thomas.
Bronchospasm during inhalation of nebulized midazolam.
British Journal of Anaesthesia, 80 (1998), pp. 564-565
[228.]
C.H.A. Walton.
Asthma associated with the use of nitrofurantoin.
Can Med Assoc J, 94 (1966), pp. 40-41
[229.]
K. Tanphaichitr.
D-penicillamine-induced bronchial spasm.
South Med J, 73 (1980), pp. 788-790
[230.]
I. Jiménez, E. Anton, I. Picans, I. Sanchez, M.D. Quinones, J. Jerez.
Occupational asthma specific to amoxicillin.
Allergy, 53 (1998), pp. 104-105
[231.]
M.C. Thompson, C. Davies.
Coughing and bronchospasm with propofol.
Anaesthesia, 45 (1990), pp. 690-691
[232.]
F.L. Lin.
Rifampin-induced deterioration in steroid-dependent asthma.
J Allergy Clin Immunol, 98 (1996), pp. 1125
[233.]
R.P. Smith, J.A. Dewar, J.H. Winter.
Tamoxifeninduced asthma.
Lancet, 341 (1993), pp. 772
[234.]
P. Matsis, S. Mann.
Rigors and bronchospasm with urokinase after streptokinase.
Lancet, 340 (1992), pp. 1552
[235.]
C.W. Turton, G.M.G. Williams.
Cryptogenic obliterative bronchiolitis in adults.
Thorax, 36 (1981), pp. 805-810
[236.]
M.A.F.J. Van De Laar, C.J.J. Westermann, S.S. Wagenaar, H.J. Dinant.
Beneficial effect of intravenous cyclophosphamide and oral prednisone on dpenicillamine-associated bronchiolitis obliterans.
Arthr Rheum, 28 (1985), pp. 93-97
[237.]
D.M. Geddes, B. Corrin, D.A. Brewerton, R.J. Da Vies, M. Turner-Warwick.
Progressive airway obliteration in adults and its association with rheuma toid disease.
Q J Med, 46 (1977), pp. 427-444
[238.]
W.H. Lyle.
D-penicillamine and fatal obliterative bronchiolitis.
Br Med J, 1 (1977), pp. 105
[239.]
L. Holness, J. Tenenbaum, N.B.E. Cooter, R.F. Grossman.
Fatal bronchiolitis obliterans associated with chrysotherapy.
Ann Rheum Dis, 42 (1983), pp. 593-596
[240.]
M. Arakawa, M. Majima, K. Nagai, F. Goto, M. Katori.
Role of tachykinins in enhancement of bradykinin-induced bronchoconstriction by captopril.
Inflamm Res, 45 (1996), pp. 75-82
[241.]
K. Umemura, M. Nakashima, T. Saruta.
Thromboxane A(2. synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors.
Life Sci, 60 (1997), pp. 1583-1588
[242.]
C. Bucknall, J. Neilly, R. Carter, R. Stevenson, P. Semple.
Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyhe inhibition.
Br Med J, 296 (1988), pp. 86-88
[243.]
J.K. Stoller, A. Elghazawi, A.C. Mehta, D.G. Vidt.
Captopril-induced cough.
Chest, 93 (1988), pp. 859-861
[244.]
P.F. Semple.
Putative mechanisms of cough after treatment with angiotensin converting enzyme inhibitors.
J Hypertension, 13 (1995), pp. S17-S21
[245.]
L.P. Boulet, J. Milot, N. Lampron, Y. Lacourciere.
Pulmonary function and airway responsiveness during long-term therapy with captopril.
JAMA, 261 (1989), pp. 413-416
[246.]
M. Usberti, J. Federico, G. Di Minno.
Effects of angiotensin II on plasma ADH, prostaglandin synthesis and water secretion in normal human.
Am J Pathol, 248 (1985), pp. 254-259
[247.]
T. Nabiks, Y. Nara, Y. Yamori, W. Lavenberg, J. Endo.
Angiotensin II and phorbol ester enhance isoproterenol and vasoactive intestinal peptide (VIP. induced cyclic AMP accumulation in vascular smooth muscle cells.
Biochem Biophys Res Commun, 131 (1985), pp. 30-35
[248.]
M.S. Orloff, A.J. Truner, N.W. Bunnet.
Catabolism of substance P and neurotensin in the ratstonach wall is susceptible to inhibitors of angiotensis converting enzyme.
Regul Pept, 14 (1986), pp. 21-31
[249.]
R.L. Conigliaro, P.P. Gleason.
Losartan-induced cough after lisinopril therapy.
American Journal of Health - System Pharmacy, 57 (2000), pp. 996-997
[250.]
P.L. Bailey.
Possible mechanism(s. of opioid-induced coughing.
Anesthesiology, 90 (1999), pp. 335
[251.]
E.E. Aly.
Persistent cough following target-controlled infusion (TCI. with propofol.
Anaesthesia, 56 (2001), pp. 1016
[252.]
P.A.M. Walden, P.F. Mitchell-Heggs, C. Coppin, J. Dent, K.D. Bagshawe.
Pleurisy and methotrexate treatment.
Br Med J, ii (1977), pp. 967
[253.]
W. Hindle, E. Posner, M.T. Sweetnam, R.S.H. Tan.
Pleural effusion and fibrosis during treatment with methysergide.
Br Med J, 1 (1970), pp. 605-606
[255.]
P.A. Lewitt, D.B. Calne.
Pleuropulmonay changes during long-term bromocriptine treatment for Parkinson’s disease.
Lancet, i (1981), pp. 44-45
[256.]
A. Man, Y. Schwarz, J. Greif.
Pleural effusion as a presenting symptom of ovarian hyperstimulation syndrome.
Eur Respir J, 10 (1997), pp. 2425-2426
[257.]
R. Jewelewicz, R.L. Vande Wiele.
Acute hydrothorax as the only symptom of ovarian hyperstimulation syndrome.
Am J Obstet Gynecol, 121 (1975), pp. 1121
[258.]
B. Clarke, D.E. Ward, M. Honey.
Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy.
Int J Cardiol, 8 (1985), pp. 81-88
[259.]
A. Tucker, A.J. Newman, C. Alvorado.
Pulmonary, pleural and thoracic changes complicating chemotherapy.
Radiology, 125 (1977), pp. 805-809
[260.]
S.E. Rossi, J.J. Erasmus, P. Mcadams, T.A. Sporn, P.C. Goodman.
Pulmonary drug toxicity: radiologic and pathologic manifestations.
Radiographics, 5 (2000), pp. 1245-1259
[261.]
A. Kok-Jensen, O. Lindeneg.
Pleurisy and fibrosis of the pleura during methysergide treatment of hemicrania.
Scand J Resp Dis, 51 (1970), pp. 218-222
[262.]
H.L. Israel, P. Diamond.
Recurrent pulmonary infiltration and pleural effusion due to nitrofurantoin sen sitivity.
N Engl J Med, 266 (1962), pp. 1024-1026
[263.]
C. Karkos, A.A.M. Moore, et al.
Pleural effusion associated with d-penicillamine therapy: a case report.
Journal of Clinical Pharmacology and Therapeutics, 21 (1996), pp. 15-17
[264.]
M. Hatzinger, R. Stohler, E. Hoslboer Trachsler.
Eosinophile pleuritis und Hepatopathie unter Trimipramin-Therapie.
Schweiz Med Wochenschr, 121 (1991), pp. 910-912
[265.]
N. Tzanakis, D. Bouros, N. Siafakas.
Eosi nophilic pleural effusion due to gliclazide.
Respiratory Medicine, 94 (2000), pp. 94
[266.]
C.B. Bunker, N. Sheron, P.D.L. Maurice, G. Kocian, N. Johnson, P.M. Down.
Isotretinoin eosi nophilic pleural effusion.
Lancet, 1 (1989), pp. 438
[267.]
N.H. Dyer, C.C. Varley.
Practolol induced pleurisy and constrictive pericarditis.
Br Med J, i (1975), pp. 443
[268.]
J. Günther, H. Lode, M. Raffenberg, T. Schaberg.
Development of pleural and pericardial effusions during itraconazole therapy of pulmonary aspergillosis.
Eur J Clin Microbiol Infect Dis, 12 (1993), pp. 723-724
[269.]
J. Saura, M. Aguilar, J. Alio.
Derrame pleural y pericarditis constrictiva secundarios al tratamiento con bromocriptina.
Neurologia, 6 (1991), pp. 331-333
[270.]
H.M.J.R. Perry, E.M. Tan, S. Carmody.
Relationship of acetyltransferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients trated with hydralazine.
J Lab Clin Med, 76 (1970), pp. 114-118
[271.]
J.R. Batchelor, K.J. Welsch, R.M. Tinoco.
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.
Lancet, i (1980), pp. 1107
[272.]
H.L. Holley.
Evidence for a predispoportaln to rheuma-toid diseases in families of patients developing drug-induced systemic lupus erythematosus.
Arth Rheum, 7 (1964), pp. 684-691
[273.]
K. Hiraoka, N. Nagata, T. Kawajiri, et al.
Paradoxical pleural response to antituberculous chemotherapy and isoniazid-induced lupus - Review and report of two cases.
Respiration, 65 (1998), pp. 152-155
[274.]
J. Bensaid, J.C. Aldigier, N. Gualde.
Systemic lupus erythematosus syndrome induced by pindolol.
Br Med J, ii (1979), pp. 1603-1604
[275.]
P. Roche-Bayard, R. Rossi, J.M. Mann, J.F. Cordier, J.P. Delahaye.
Left pulmonary artery thrombosis in chlorpromazine-induced lupus.
Chest, 98 (1990), pp. 1545
[276.]
N. Rosenfeld, S. Yeche, D. Reynaud, L. Abiad, A. Dubois.
Acute disseminated lupus erythematosus. Responsibility of Corenitec: a propos of a case.
Therapie, 54 (1999), pp. 493-494
[277.]
C. Sieber, E. Grimm, F. Follah.
Captopril and systemic lupus erythematosus syndrome.
Br Med J, 301 (1990), pp. 669
[278.]
D. Leak.
Absence of cross-reaction between lisinopril and enalapril in drug-induced lupus.
Ann Pharmacother, 31 (1997), pp. 1406-1407
[279.]
S. Alballa, M. Fritzler, P. Davis.
A case of drug-induced lupus due to carbamazepine.
J Rheumatol, 14 (1987), pp. 599-600
[281.]
G.L. Clementz, B.J. Dolin.
Sulfasalazine-induced lupus erythematosus.
Am J Med, 84 (1988), pp. 535-538
[282.]
R.W. Burlingame.
The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus.
Clin Lab Med, 17 (1997), pp. 367-378
[283.]
K.S. Wilson, M.L. Brigden, S. Alexander, A. Worth.
Fatal pneumothorax in “BCNU lung”.
Med Pediatr Oncol, 10 (1982), pp. 195-199
[284.]
H.G. Klein, W.R. Bell.
Disseminated intravascular coagulation during heparin therapy.
Ann Intern Med, 80 (1974), pp. 477-481
[285.]
W.R. Bell, P.A. Tourasulo, B.M. Alving, T.P. Duffy.
Thrombocytopenia occurring during the administration of heparin: a prospective study in 51 patients.
Ann Intern Med, 85 (1976), pp. 155-160
[286.]
C. Lima.
Terapêutica hormonal de substituição: tromboembolismo venoso e cancro da mama.
Bol Farmacovigil, 4 (2000), pp. 4
[287.]
H.P. Gurtner, M. Gertsch, G. Salzmann, et al.
Haufen sich die primar vaskularen formen des chronischen cor pulmonale?.
Schweiz Med Woch, 98 (1968), pp. 1579-1583
[288.]
P. Wirz, U. Arbenz.
Primar vaskulare pulmonale hypertonie in der Schweiz 1965-1970.
Schweiz Med Wschr, 100 (1970), pp. 2147-2150
[289.]
H.P. Gurtner.
Hypertension pulmonaire, “artériopathie pulmonaire-plexogénique” et aminorex: cause ou coincidence?.
Bull Eur Physiopathol Respir, 15 (1979), pp. 897-923
[290.]
S. Fruehauf, S. Steiger, J. Topaly, A.D. Ho.
Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia.
Annals of Hematology, 80 (2001), pp. 308-310
[291.]
A.T. Masi.
Pulmonary hypertension and oral contraceptive usage.
Chest, 69 (1976), pp. 451-453
[292.]
J.G. Douglas, J.F. Munro, A.H. Kitchin, A.L. Muir, A.T. Proudfoot.
Pulmonary hypertension and fenfluramine.
Br Med J, 283 (1981), pp. 881-883
[293.]
E. Lowenstein, W.E. Johnston, D.G. Lappas, et al.
Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin.
Anesthesiology, 59 (1983), pp. 470-473
[294.]
J.N. Townend, D.H. Roberts, R.L. Jones, M.K. Davies.
Fatal pulmonary venoocclusive disease after use of oral contraceptives.
Am Heart J, 124 (1992), pp. 1643-1644
[295.]
L. Lichtenstein, L.J. Fox.
Necrotizing arterial lesions resembling those of periarteritis nodosa and focal visceral necrosis following administration of sulfathiazole.
Am J Pathol, 22 (1946), pp. 665-671
[296.]
J. Arzobski, J. Ferry, D. Wombolt, D.M. Fitch, J.D. Egan.
Vasculitis with allopurinol therapy.
Am Heart J, 79 (1970), pp. 116-121
[297.]
R.P. Mccombs.
Systemic “allergic” vasculitis. Clinical and pathological relationships.
JAMA, 194 (1965), pp. 157-162
[298.]
S. Bilgrami, J. Hasson, P.J. Tutschka.
Fat embolism.
N Engl J Med, 340 (1999), pp. 393-394
[299.]
J.T. McCarthy, B.A. Staats.
Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
Chest, 89 (1986), pp. 608-611
[300.]
Ch. Collis.
Lung damage from cytotoxic drugs.
Cancer chemotherapy and pharmacology, 4 (1980), pp. 17-27
[301.]
R.P. Abratt, R. Sealy, C.J. Uys, R. Lawson.
Lymphadenopathy associated with diphenylhydantoin therapy.
Clin Oncol, 8 (1982), pp. 351-356
[302.]
G. Goldstein.
Sarcoid reaction associated with phenylbutazone hypersensitivity.
Ann Intern Med, 59 (1963), pp. 97-100
[303.]
E. Bobbio-Pallavicini, C. Valsecchi, F. Tacconi, M. Moroni, C. Porta.
Sarcoidosis following betainterferon therapy for multiple myeloma.
Sarcoidosis, 12 (1995), pp. 140-142
[304.]
M. Yonemaru, Y. Mizuguchi, I. Kasuga, K. Ut-Sumi, Y. Ichinose, K. Toyama.
Hilar and mediastinal lymphadenopathy with hypersensitivity pneumonitis induced by penicillin.
Chest, 102 (1992), pp. 1907-1909
[305.]
J. Diebold, J.-M. James, C. Dao, et al.
Hyperplasie lymphoïde immunoblastique pseudo-tumorale par hypersensibilité médicamenteuse.
Arch Anat Cytol Pathol, 24 (1976), pp. 189-194
[306.]
M.J. Lapes, R.J. Vivacqua, K. Antoniades.
Immunoblastic lymphadenopathy associated with phenytoin (diphenylhydantoin.
Lancet, i (1976), pp. 198
[308.]
S.F. Bodman, J.J. Condemi.
Mediastinal widening in iatrogenic Cushing’s syndrome.
Ann Intern Med, 67 (1967), pp. 399-403
[309.]
H.S. Glazer, M.R. Wick, D.J. Anderson, et al.
CT of fatty thoracic masses.
Am J Roentgenol, 159 (1992), pp. 1181-1187
[310.]
R.M. Hoffmann, M.C. Jung, R. Motz, et al.
Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
J Hepatol, 28 (1998), pp. 1058-1063
[311.]
N.J. Vanderels, H. Gerdes.
Sarcoidosis and IFNalpha treatment.
Chest, 117 (2000), pp. 294
[312.]
A.P. Kourtis, C. Abramowsky, C. Ibegbu, L. Kobrynski.
Enlargement of the thymus in a child with chronic granulomatous disease receiving interferon gamma therapy.
Arch Pathol Lab Med, 122 (1998), pp. 562-565
[313.]
C. Taillé, M. Fartoukh, R. Houël, H. Kobeiter, P. Rémy, F. Lemaire.
Spontaneous hemomediastinum complicating steroid-induced mediastinal lipomatosis.
Chest, 120 (2001), pp. 311-313
[314.]
Z.H. Israili, W.D. Hall.
Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy.
Ann Intern Med, 117 (1992), pp. 234-242
[315.]
J.L. Ulmer, M.J. Garvey.
Fatal angioedema associated with lisinopril.
Ann Pharmacother, 26 (1992), pp. 1245-1246
[316.]
H. Mithani, T.A. Hurwitz.
Paroxetine-induced angioedema and tongue swelling.
J Clin Psychiatry, 57 (1996), pp. 486
[317.]
R.R. Schellenberg, S.H. Isserow.
Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor.
N Engl J Med, 345 (2001), pp. 1856
[318.]
A.S. Jungling, R.E. Shangraw.
Massive airway edema after azathioprine.
Anesthesiology, 92 (2000), pp. 888-890
[319.]
A.F. Cohen, S.P. Warman.
Upper airway obstruction secondary to warfarin-induced sublingual hematoma.
Arch Otolaryngol, 115 (1989), pp. 718-720
[320.]
A.M. Kaynar, K. Bhavani-Shankar, P.S. Mushlin.
Lingual hematoma as a potential cause of upper airway obstruction.
Anesthesia and Analgesia, 89 (1999), pp. 1573-1575
[321.]
H. Geldmacher, C. Taube, U. Markert, D.K. Kirsten.
Nearly fatal complications of cervical lymphadenitis following BCG immunotherapy for superficial bladder cancer.
Respiration, 68 (2001), pp. 420-421
[322.]
S.K. Barnung, M. Treschow, F.M. Borgbjerg.
Respiratory depression following oral tramadol in a patient with impaired renal function.
Pain, 71 (1997), pp. 111-112
[323.]
E. Lang, R. Jedeikin.
Acute respiratory depression as a complication of nebulised morphine.
Can J Anaesth, 45 (1998), pp. 60-62
[324.]
S.L. Bowyer, M.P. Lamothe, J.R. Hollister.
Steroid myopathy: incidence and detection in a population with asthma.
J Allergy Clin Immunol, 76 (1985), pp. 234-242
[325.]
K. Ray-Chauduri, I.F. Pye, M. Boggild.
Hypersensibivity to carbamazepine presenting with a leuke moid reaction, eosinophilia, erythroderma, and renal failure.
Neurology, 39 (1989), pp. 436-438
[326.]
B.F. Clarke, I.W. Campbell, D.J. Ewing, G.W. Beveridge, M.K. MacDonald.
Generalized hypersensitivity reaction and visceral arteritis with fatal outcome during glibenclamide therapy.
Diabetes, 23 (1974), pp. 739-742
[327.]
D.R. Thickett, A.B. Millar.
Drug-induced antisynthetase syndrome.
Postgrad Med J, 73 (1997), pp. 165-166
[328.]
S. Hovenga, M.E.F. Koenders, T.S. Van Der Werf, H. Moshage, J.G. Zijlstra.
Methaemoglobinaemia after inhalation of nitric oxide for treatment of hydrochlorothiazide-induced pulmonary oedema.
Lancet, 348 (1996), pp. 1035-1036
[329.]
U. Dührsen, V. Heinrichs, W.D. Beecken, K. Herbst, K. Mross, D.K. Hossfeld.
Local and systemic sequelae of mediastinal daunorubicin extravasation in a patient with acute myelomonocytic leukemia.
Ann Oncol, 8 (1997), pp. 1167-1168
[330.]
K.S. Kristensen, A. Hoegholm, L. Bohr, S. Friis.
Fatal myocarditis associated with mesalazine.
Lancet, 335 (1990), pp. 605
[331.]
M. Kritjansson, P. Green, H.L. Manning, et al.
Molecular confirmation of Bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation.
Clin Infect Dis, 17 (1993), pp. 228-230
[332.]
D. Foster.
R. Miliary tuberculosis following intravesical BCG treatment.
Br J Radiol, 70 (1997), pp. 429
[333.]
E.A. Talbot, M.D. Perkins, S.F.M. Silva, R. Frothingham.
Disseminated Bacille Calmette-Guérin disease after vaccination: Case report and review.
Clin Infect Dis, 24 (1997), pp. 1139-1146
[334.]
P.A. Kouides, C.A. Slapak, L.J. Rosenwasser, K.B. Miller.
Pneumocystis carinii pneumonia as a complication of deferoxamine therapy.
Br J Haematol, 70 (1988), pp. 383-384
[335.]
S.F. Dowell, J.S. Bresee.
Severe varicella associated with steroid use.
Pediatrics, 92 (1993), pp. 223-228
[336.]
R. Menéndez, P.J. Cordero, M. Santos, M. Gober Nado, V. Marco.
Pulmonary infection with Nocardia species: a report of 10 cases and review.
Eur Respir J, 10 (1997), pp. 1542-1546
[337.]
M. Setoyama, S. Fukumaru, T. Takasaki, H. Yoshida, T. Kanzaki.
SLE with death from acute massive pulmonary hemorrhage caused by disseminated strongyloidiasis.
Scand J Rheumatol, 26 (1997), pp. 389-391
[338.]
A.H. Groll, G. Jaeger, A. Allendorf, G. Herrmann, R. Schloesser, V. Von Loewenich.
Invasive pulmonary aspergillosis in a critically ill neonate: Case report and review of invasive aspergillosis during the first 3 months of life.
Clin Infect Dis, 27 (1998), pp. 437-452
[339.]
A. Grigg, R. Chapman, J. Szer.
Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine.
Bone Marrow Transplantation, 21 (1998), pp. 619-621
[340.]
K.W.T. Tsang, P.S.P. Lam, K.Y. Yuen, C.C.G. Ooi, W. Lam, M. Ip.
Rhodococcus equi lung abscess complicating Evan’s syndrome treated with corticosteroid.
Respiration, 65 (1998), pp. 327-330
[341.]
A.J. Fairfax, V. David, G. Douce.
Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma.
Thorax, 54 (1999), pp. 860-861
[342.]
B.A. Leav, B. Fanburg, S. Hadley.
Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone.
N Engl J Med, 343 (2000), pp. 586
[343.]
R. Pombal.
A Farmacovigilância na NET.
Bol Farmacovigil, 4 (2000), pp. 1-4
Copyright © 2002. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
- Comparison of different field tests to assess the physical capacity of post-COVID-19 patients
- New insights in circulating peptidome to differentiate mild to severe COVID-19 patients: Preliminary report
Recommended
articles
articles
10.1016/j.pulmoe.2022.09.007
Pulmonol. 2020;26:101-3
Pulmonol. 2020;26:95-100
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options